INTRODUCTION
============

Integrons are genetic elements commonly found in gram-negative bacteria either as sedentary chromosomal components or embedded in transposons ([@B1],[@B2]). They have the capability to incorporate promoterless gene cassettes site-specifically in proximity to a promoter (P~C~) and thereby allow the expression of the gene carried by the cassette ([@B1]). The integron platform consists of a tyrosine recombinase encoding gene, the promoter P~C~, and the *attI* insertion site where the cassette integration occurs. We recently reported that integrase expression is triggered during the SOS response ([@B3]). Integrative recombination takes place between a gene cassette recombination site, the *attC* site (or 59 bp element) which can greatly vary in length and sequence, and the *attI* site of the integron platform ([@B1]). Recombination can also occur via two flanking *attC* sites (*attC* × *attC* recombination), resulting in excision of a gene cassette from the integron, or between two *attI* sites, a reaction whose biological relevance is not yet known ([@B4; @B5; @B6]). Integrons are classified according to the integrase they encode, with two paradigmatic systems, the class 1 integron for the mobile integrons and the *Vibrio cholerae* superintegron for the sedentary ones ([@B1]). Previous work on class 1 integrons, defined by the encoded IntI1 integrase, has shown that only the *attC* site bottom strand was recombined after folding of the single-stranded (ss) DNA over the palindromic sequence that defines the *attC* site ([@B7]). The ss folding generates the proper substrate for recombination and the recombined strand selection is directed by unpaired nucleotides (nt) ([@B8],[@B9]) ([Figure 1](#F1){ref-type="fig"}). The *attI1* site, however, is in canonical double stranded form during the process ([@B7]). Additionally, IntI1 accepts several distinct *attC* sites as substrate, while it only efficiently recognizes its own *attI1* site ([@B5],[@B10],[@B11]). The recognition characteristics of IntI1 mean that very little sequence identity is necessary between *attC* and *attI1*. In particular, and in contrast to most other tyrosine recombinase substrates which require a common 6--8 nt core sequence, only three completely conserved nts, GTT, are observed ([@B1],[@B12; @B13; @B14]) ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Figure 1.Sequence of the substrates used in this study. Bottom strand sequence and folding of the *attC*~aadA7~ (**A**), *attC*~VCR~ (**B**), *attC*~VCRd~ (**C**), and *attC*~VCRdINV~ (**D**). (**E**) Sequence of the double strand attI1 site core. The cleavage site, G1T2T3/A^1′^A^2′^A^3′^, is indicated for each substrate. Figure 2.(**A**) Holliday Junction with the sequence of *attI1* and *attC*~aadA7~bs. The *attI1* sequence is represented in black, with the cleavage site in red and the *attC*~aadA7~bs sequence is in blue, with the cleavage site in purple. The presumed IntI1 binding sites are boxed. (**B**) Amino acid interactions of IntI1 and VchIntIA with the cleavage site, based on the crystal structure of the VchIntIA synaptic complex. The amino acids of IntI1 are written in black and the corresponding aa of VchIntIA is in grey in parenthesis. 'A' means that the amino acid is from the active subunit and 'sym' means that the interactions of this amino acid from active and the non-active subunits are equivalent ([@B8]).

The crystal structure of the integron integrase VchIntIA, from the *V. cholerae* superintegron, bound to the ss *attC* in the synaptic complex substrate representing the excising complex (*attC* × *attC* recombination), has been solved ([@B8]). This crystal structure has been used to model the highly similar (65% identity) IntI1 ([@B15]). These structures show no base specific interaction between the first nt of the cleavage site and the integrase ([@B8]). This led to the hypothesis that the conserved G^1^ in the G^1^T^2^T^3^ triplet is conserved because of the requirement for identity between the sites, rather than the properties of the base itself. Furthermore, analysis of the VchIntIA structure and our IntI1 model reveals that the only amino acid (aa) that shows base specific interactions with the three conserved nt of the cleavage site, is the conserved lysine aa K171 (K160, in VchIntIA numbering), which interacts with the last T of the GTT triplet and the middle nt A of the opposite strand ([Figure 2](#F2){ref-type="fig"}B). The remainder of the aa, which are known or predicted to interact with the cleavage site, do so with the phosphate backbone only, and many of these interactions are weak (more than 3.5 Å away) ([@B8]). In this work, the cleavage site sequence has been dissected to elucidate the importance of the respective nt of the GTT triplet in the recombination reaction, using the cleavage site of *attC*~aadA7~ ([Figure 1](#F1){ref-type="fig"}). We show that the first nt is responsible for the docking and that the base in itself is indifferent to the cleavage and strand-exchange reaction. This is consistent with the requirement for micro-homology readout in tyrosine recombinase site specific recombination ([@B16]), with the novelty that in class 1 integron, *attC* × *attI1* recombination, only one-nt is required for this. Furthermore, we found that mutations in the second and third nt in either the *attC* or the *attI1* site, still yields full recombination products, whereas the same mutation can be detrimental when present on both sites simultaneously.

MATERIALS AND METHODS
=====================

Bacterial strains, plasmids and media
-------------------------------------

Bacterial strains and plasmids are described in [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. *Escherichia coli* strains were grown in Luria-Bertani (LB) at 37°C. Antibiotics were used at the following concentrations: ampicillin (Ap), 100 µg/ml; chloramphenicol (Cm), 25 µg/ml; kanamycin (Km), 25 µg/ml. Diaminopimelic acid (DAP) was supplemented when necessary to a final concentration of 0.8 mM. IPTG (isopropyl-β-[d-]{.smallcaps}thiogalactopyranoside) was added at 0.8 mM final concentration. Chemicals were from Sigma. Table 1.Bacterial strains used in this study*Escherichia coli* strainsPertinant feature(s)Origin or referenceDH5α(F^−^) *supE44 ΔlacU169 (Φ80lacZΔM15)ΔargF hsdR17 recA1 endA1 gyrA96 thi-1 relA1*Laboratory collectionUB5201F-pro met recA56 gyrA \[Nal\]^R^([@B25])β2163(F^−^) RP4-2-Tc::Mu *ΔdapA*::(*erm-pir*) \[Km^R^ Em^R^\]([@B26])BL21(DE3)pLysS*E. coli* B strain containing the T7 polymerase and plasmid pLysS expressing T7 lysozyme([@B27]) Table 2.Plasmids used in this studyPlasmidsDescriptionOrigin or referencep1266pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^([@B15])p112pTRC99A::*intI1*, *ori*~ColE1~ \[Ap\]^R^([@B28])p4634pET3a::*HisInt* \[Ap\]^R^([@B15])p10000pET3a::*HisInt* ~Y37F~\[Ap\]^R^This workp4632pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~wt~. *attI1* starts --81nt from the cross-over pointThis workp4867pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteATT~This workp5060pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteCTT~This workp5059pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteTTT~This workp4761pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteGAT~This workp4669pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteGGT~This workp4671pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteGTA~This workp5019pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteGTC~This workp4674pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteGAA~This workp5020pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteGGG~This workp7817pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1*~cleavagesiteGTG~This workp929pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1long*~wt~([@B7])p4394pSU38Δ*lacZα, ori*~p15A~ \[Km\]^R^\_*attI1long*~cleavagesiteGCT~This workp3030pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7wt~([@B7])p8144pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteG1T2T3\ --\ A1′T2′C3′~This workp4741pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteATT~This workp6751pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteCTT~This workp6009pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteTTT~This workp4986pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteGAT~This workp4397pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteGCT~This workp4739pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteGGT~This workp4740pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteGTA~This workp6787pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteGTC~This workp4738pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteGAA~This workp5017pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteGGG~This workp7524pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~aadA7cleavagesiteGTG~This workp4907pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~VCRd~([@B9],[@B15])p4836pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~VCRdbulgeinversed~([@B9],[@B15])p7138pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~VCRdbulgeinversedcleavagesiteTTT~This workp7137pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~VCRdcleavagesiteTTT~This workp8141pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~VCRdcleavagesiteGTC~This workp8140pSW23T, oriT_RP4 \[Cm\]^R^\_*attC*~VCRdcleavagesiteGCT~This work

PCR procedures
--------------

PCR reactions for topo cloning were performed using GoTaq polymerase (Promega). PCR reactions for site-directed mutagenesis (SDM) used the Pfu turbo polymerase (Stratagene). The primers listed in [Table 3](#T3){ref-type="table"}, were from Sigma-Aldrich (France). Table 3.Oligonucleotides used in this studyOligosSequences*Plasmid construction*R1attI1wt`GAATTCAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCC`H1attI1wt`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTAACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~ATT~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTAATTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~CTT~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTAAGTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~TTT~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTAAATTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~GAT~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTATCTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`attI1~GCT~sdm`CGCCCTAAAACAAAGCTAGGCATCACAAAGTACAG`attI1~GCT~sdm`CTGTACTTTGTGATGCCTAGCTTTGTTTTAGGGCG`H1attI1~GGT~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTACCTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~GTA~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTTACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~GTC~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTGACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~GTG~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTCACTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~GAA~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTTTCTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`H1attI1~GGG~`GGATCCTGTTGGTCACGATGCTGTACTTTGTGATGCCTCCCTTTGTTTTAGGGCGACTGCCCTGCTGCGTAACATCG`R1attC~ATT~`GAATTCATGTCTAATAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~ATT~`GGATCCATGTCTAATGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`H1attC~CTT~`GGATCCATGTCTAAGAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`Sal11 attC~CTT~`CCGCGGATGTCTAAGGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~TTT~`GAATTCATGTCTAAAAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~TTT~`GGATCCATGTCTAAAGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~GAT~`GAATTCATGTCTATCAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~GAT~`GGATCCATGTCTATCGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~GCT~`GAATTCATGTCTAGCAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~GCT~`GGATCCATGTCTAGCGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~GGT~`GAATTCATGTCTACCAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~GGT~`GGATCCATGTCTACCGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~GTA~`GAATTCATGTCTTACAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~GTA~`GGATCCATGTCTTACGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~GTC~`GAATTCATGTCTGACAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~GTC~`GGATCCATGTCTGACGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~GTG~`GAATTCATGTCTCACAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~GTG~`GGATCCATGTCTCACGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~GAA~`GAATTCATGTCTTTCAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~GAA~`GGATCCATGTCTTTCGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`R1attC~GGG~`GAATTCATGTCTCCCAATTCATTCAAGCCGACGCCGCTTCGCGGCGCGGCT`H1attC~GGG~`GGATCCATGTCTCCCGCTTGAATTAAGCCGCGCCGCGAAGCGGCGTCG`IntI1Y37Fbot`GGCACGAACCCAGTGGACAAAAGCCTGTTCGGTTCGTAAGC`IntI1Y37Ftop`GCTTACGAACCGAACAGGCTTTTGTCCACTGGGTTCGTGCC`*PCR*MFD`CGCCAGGGTTTTCCCAGTCAC`SW23begin`CCGTCACAGGTATTTATTCGGCG`

Plasmid constructions
---------------------

The plasmids with mutations in the G^1^T^2^T^3^ cleavage sites were constructed by assembling two long partially hybridizing primers ([Table 3](#T3){ref-type="table"}) for the different recombination sites harboring, an EcoR1 and a BamH1 site at their respective ends. These were then subjected to PCR, cloned into vector pCR2.1 TOPO (Invitrogen) and transformed into Top10 competent cells (Invitrogen). After sequencing, clones carrying the desired recombination site were cleaved with EcoR1 and BamH1 and ligated into vectors pSU38Δ (p1266) for the *attI1* sites, and pSW23T (26) for the *attC* sites. The *attC*~aadA7CTT~ was generated within the sites Sal1 and BamH1.

pET3a_HisIntI1~Y37F~ was constructed using SDM with pET_HisIntI1 as a template ([@B15]).

Integration assay
-----------------

The integration assay was performed as described ([@B7]) with the following modifications. After concentration of the recipient and donor cells on a 0.45 µm filter, the bacteria were incubated at 37°C for 5 h on LB plates with DAP and plated on the appropriate antibiotics. The recombination frequency was calculated as the ratio of Cm and nalidixic acid (antibiotic resistance markers of the donor plasmid and the recipient strain UB5201) resistant cells over the number of Km and Ap (antibiotic resistance markers of the plasmids carrying the *attI1* site and *intI1*) resistant cells. The correct recombination site was verified by PCR using at least eight randomly picked colonies. The number of correct clones thus identified was multiplied by the value for the original frequency to eliminate the background colonies. For clones with efficient recombination such as the wild-type (wt), the number of correct clones was usually 8/8, however, with clones having poor recombination efficiency the number of correct clones could be as little as 1/8, where the others had recombined into secondary sites. The recombination frequencies presented in [Table 4](#T4){ref-type="table"} are the average of at least three experiments, normalized to that obtained with the wt. The wt frequency is 2.2 × 10^−3^, except for mutations GTT→GCT, which were performed with plasmid p929 containing a longer *attI1* fragment than p4632, and the wt recombination frequency was found to be 3.45 × 10^−2^. Table 4.Recombination frequencies of the different cleavage site mutants after normalization with the wt *attC*~aadA7~ × *attI1* recombination frequency or wt *attC*~VCRd~ × *attI1* recombination frequencyAMutations in nucleotide nr 1 of the G^1^T^2^T^3^ cleavage site^a^*attC*~aadA7~/*attI1**ATT***3.4 × 10^−3^*attC*~aadA7~***ATT***/*attI1*3.1 × 10^−3^*attC*~aadA7~***ATT***/*attI1**ATT***1(2.3 × 10^−3^)(4.1 × 10^−3^)(6.4 × 10^−1^)*attC*~aadA7~/*attI1**CTT***1.5 × 10^−4^*attC*~aadA7~***CTT***/*attI1*1.5 × 10^−3^*attC*~aadA7~***CTT***/*attI1**CTT***9.7 × 10^−1^(2.5 × 10^−4^)(1.7 × 10^−3^)(3.4 × 10^−1^)*attC*~aadA7~/*attI1**TTT***none detected*attC*~aadA7~***TTT***/*attI1*2.1 × 10^−4^*attC*~aadA7~***TTT***/*attI1**TTT***4.4 × 10^−2^(2.1 × 10^−4^)(4.3 × 10^−2^)BMutations in nucleotide nr 2 of the G^1^T^2^T^3^ cleavage site*attC*~aadA7~/*attI1**GAT***4.6 (3.8)*attC*~aadA7~***GAT***/*attI1*1.9 (0.9)*attC*~aadA7~***GAT***/*attI1**GAT***3.2 (2.7)*attC*~aadA7~/*attI1**GCT***2.1 (1.39)*attC*~aadA7~***GCT***/*attI1*1.5 × 10^−1^*attC*~aadA7~***GCT***/*attI1**GCT***4.1 × 10^−2^(1 × 10^−1^)(1.9 × 10^−2^)*attC*~aadA7~/*attI1**GGT***9.6 × 10^−1^*attC*~aadA7~***GGT***/*attI1*1*attC*~aadA7~***GGT***/*attI1**GGT***7.1 × 10^−1^(5.7 × 10^−1^)(5.8 × 10^−1^)(4.3 × 10^−1^)*attC*~VCRd~*/attI1**GCT***8.7 × 10^−1^*attC*~VCRd~***GCT**/attI1*4.8 × 10^−1^*attC*~VCRd~*GCT/attI1**GCT***3.6 × 10^−2^(1.4 × 10^−1^)(2.7 × 10^−2^)(2.7 × 10^−2^)CMutations in nucleotide nr 3 of the G^1^T^2^T^3^ cleavage site*attC*~aadA7~/*attI1**GTA***1.3 (1.1)*attC*~aadA7~***GTA***/*attI1*5.6 × 10^−1^*attC*~aadA7~***GTA***/*attI1**GTA***5.6 × 10^−2^(3.6 × 10^−1^)(1.5 × 10^−2^)*attC*~aadA7~/*attI1**GTC***1.9 (1.5)*attC*~aadA7~***GTC***/*attI1*1 (7.3 × 10^−1^)*attC*~aadA7~***GTC***/*attI1**GTC***5.6 × 10^−3^(2.5 × 10^−3^)*attC*~aadA7~/*attI1**GTG***9.4 × 10^−1^*attC*~aadA7~***GTG***/*attI1*7.3 × 10^−2^*attC*~aadA7~***GTG***/*attI1**GTG***1.2 × 10^−2^(5.1 × 10^−1^)(4.1 × 10^−2^)(9.8 × 10^−3^)*attC*~VCRd~*/attI1**GTC***2.6 × 10^−1^*attC*~VCRd~***GTC**/attI1*4.4 × 10^−2^*attC*~VCRd~***GTC**/attI1**GTC***4.8 × 10^−5^(2.1 × 10^−1^)(2.4 × 10^−2^)(2.4 × 10^−4^)DMutations in nucleotides nr 2 and 3 of the G^1^T^2^T^3^ cleavage site*attC*~aadA7~/*attI1**GAA***7.5 × 10^−1^*attC*~aadA7~***GAA***/*attI1*4.4 × 10^−1^*attC*~aadA7~***GAA***/*attI1**GAA***1.2 × 10^−3^(2.8 × 10^−1^)(1.3 × 10^−3^)(3.7 × 10^−1^)*attC*~aadA7~/*attI1**GGG***1.1 × 10^−1^*attC*~aadA7~***GGG***/*attI1*7.3 × 10^−3^*attC*~aadA7~***GGG***/*attI1**GGG***1.6 × 10^−5^(5.5 × 10^−3^)(3.4 × 10^−2^)(1.1 × 10^−5^)[^2][^3]

Protein purification
--------------------

Protein purification was carried out as described previously ([@B15]).

EMSA
----

Each reaction contained 50 ng polyDI--polyDC, 12 mM Hepes--NaOH pH 7.7, 12% glycerol, 4 mM Tris--HCl pH 8.0, 60 mM KCl, 1 mM EDTA, 0.06 µg/µl BSA, 1 mM DTT, 200 mM imidazole, 5 mM phosphate, 125 mM NaCl, 0.6 pmol P^32^-labeled probe and the amount of protein indicated in the figure, in a final volume of 20 µl. The samples were incubated 30°C for 10 min before loaded to a 5% native polyacrylmide gel (30% Acrylamide/Bis Solution, 29:1 BioRad), with 1× TBE as buffer. The gel was run at 20 mA with room temperature water as cooling and 0.5× TBE as running buffer, for ∼2 h. The gels were dried prior to autoradiography and visualized using a Phosphor Imager 445 SI (Molecular dynamics). Quantifications were made using the Image Gauge version 4.0.0 (FUJI Photo Film Co. Ltd), manually defining the lanes and using the automatic peak search function. All other functions were at default values.

Cleavage assay
--------------

The cleavage assay was performed as above until the incubation step. Afterwards, denaturing stop solution was added, and the sample loaded onto a 5% denaturing polyacrylmide gel with 1% of SDS. SDS (0.1%) was added in the sample buffer. In the reactions, 30 pmol of the appropriate protein was used. The covalently bound DNA--protein complex will migrate at a slower rate relative to free DNA and make a shift on the gel.

RESULTS
=======

The first-nt of the GTT triplet requires homology between the *attC* and *attI1* for effective recombination
------------------------------------------------------------------------------------------------------------

In the literature, the sequence of the cleavage site is denoted GTT while in fact cleavage occurs on the opposite strand, between the A and the C of AAC. Thus, the wt site will here be described as GTT (or G^1^T^2^T^3^) and the mutants made for this study will be identified as mutations thereof. The opposite strand will be denoted A^1′^A^2′^C^3′^ ([Figure 1](#F1){ref-type="fig"}).

Because of the ss folded structure of the *attC* site, two complementary mutations are necessary at this site to ensure the complementarity of the folded strand ([Figure 1](#F1){ref-type="fig"}). The recombination frequency between an *attC*~aadA7~ site with a non-complementary cleavage site G^1^T^2^T^3^ -- A^1′^T^2′^C^3′^ and the *attI1*~wt~, is 6 × 10^−6^ while the wt (G^1^T^2^T^3^--A^1′^A^2′^C^3′^) *attC*~aadA7wt~ × *attI1*~wt~ recombination frequency is 2.2 × 10^−3^. The chance of the same spontaneous mutations in 3 nt of the *attI1* and *attC* sites at once, is very low, (1/4 × 10^−9^)^3^, assuming a probability for a base pair to be mutated to 10^−9^ per bacterial generation ([@B17]). This means that the need for complementary nts upon strand exchange in order to achieve effective recombination is highly conserved and to find the corresponding match of a mutated nt in the facing substrate mutated as well is quite unlikely. We constructed *attC* site mutants, where we modified both complementary positions of the site. Recombination experiments testing mutations of the G^1^/C^3′^ in only one or the other of the two partner sites, the *attC*~aadA7~ and *attI1*~wt~, sites yield a frequency that is 10^3^--10^4^ times lower than the frequency obtained with two wt sites ([Table 4](#T4){ref-type="table"}). However, when performed with the partner site carrying the same mutation the recombination frequency is fully restored. The reason for this becomes evident when looking at the schematic picture of the recombination event in [Figure 2](#F2){ref-type="fig"}A. In order for the hybridization of the exchanging DNA strand to occur on the synapsed DNA molecule, complementarity is mandatory.

However, the mutation G^1^→T^1^ differs from this pattern, in the sense that it is still 20 times lower compared to the wt, when both the *attC*~aadA7~ and *attI1* sites carry this mutation ([Table 4](#T4){ref-type="table"}). The sequence of the *attC*~aadA7~ substrate, exposes three possible Ts as docking sites for the invading A^3′^ from the *attI1* DNA molecule ([Figure 2](#F2){ref-type="fig"}A), since after cleavage, two Ts from the bulge of *attC*~aadA7~ will be liberated. Docking at the wrong position by the invading strand would prevent ligation of the two DNA strands and therefore inhibit the resolution of the Holliday junction. We hypothesize that the cleavage site G^1^→T^1^ is poor because of the additional possibilities for docking. To verify this, we inversed the bulge of a modified *attC*~VCR~ substrate and used the mutant IntI1~P109L~ for recombination. The IntI1~P109L~ mutant has been shown to recombine *attC*~VCR~ mutant substrates with an inversed bulge, *attC*~VCRINV~, efficiently, although not as well as it recombines the wt substrate ([@B15]). The inversion has a drastic effect on recombination with the IntI1~wt~ protein ([@B9],[@B15]). Using the modified *attC*~VCR~ substrate, *attC*~VCRd~ ([Figure 1](#F1){ref-type="fig"}) ([@B9],[@B15]), we were able to show that the possibility of docking at many places most likely plays a role in the decrease in activity of the G^1^→T^1^ substrate. Indeed, G^1^→T^1^ mutation in both the *attC*~VCRd~ and *attI1* sites (*attC*~VCRdTTT~/*attI1*~TTT~, [Figure 3](#F3){ref-type="fig"}A) leads to a 100-fold decrease of the recombination compared to the frequency of the *attC*~VCRd~/*attI1*~wt~ substrates. On the other hand when using the substrate with the inversed bulge, *attC*~VCRdINV~ ([Figure 1](#F1){ref-type="fig"}), we found that introduction of the same G^1^→T^1^ mutation in the two partner site (*attC*~VCRdINVTTT~/*attI1*~TTT~, [Figure 3](#F3){ref-type="fig"}B), the recombination frequency decreases by 10-fold only (compared with the frequency of the *attC*~VCRdINV~/*attI1*~wt~ substrates). In this case, the *attC*~VCRdINV~ site will allow only one pairing possibility for the mutant T^1^, on the invading strand, carrying mutation A^1′^. Figure 3.(**A**) Integration assay frequencies of recombination of *attC*~VCRd~ mutant sites with *attI1*~wt~ and *attI1*~TTT~, by the mutant IntI1~P109L~. (**B**) Integration assay frequencies of recombination of *attC*~VCRdINV~ mutant sites with *attI1*~wt~ and *attI1*~TTT~, by the mutant IntI1~P109L~. (**C**) Integration frequency of *attC*~VCR~ and *attI1*~wt~ by the integrase mutants IntI1~K171R~ and IntI1~K171A~.

The second nt of the GTT triplet
--------------------------------

The outcome of the mutations in T^2^ is interesting for several reasons. In contrast to mutations in G^1^, the (T^2^→A^2^, T^2^→C^2^ or T^2^→G^2^) mutations with their complementary positions modified, do not follow the same general pattern ([Table 4](#T4){ref-type="table"}). The few significant variations from the wt substrates are both increase and decrease in the recombination efficiency. In general, the second position of the G^1^T^2^T^3^ triplet is quite tolerant to mutations in *attC* × *attI1* recombination. It is thus evident that *attC* × *attI1* recombination is not dependent on the identity of the second nt of the cleavage site between the two substrates. With the mutation T^2^→A^2^ we see an increase in recombination frequency, while the only large decrease in recombination frequency in this group is a 30-fold drop in recombination between *attC*~aadA7GCT~ × *attI1*~GCT~. The recombination frequency of *attC*~aadA7wt~ × *attI1*~GCT~ is unaffected, while *attC*~aadA7GCT~ × *attI1*~wt~ shows an ∼6-fold decrease. We confirmed these results to be due to cleavage and not to a disruption of the *attC*~aadA7~ site due to the mutation, by using the *attC*~VCRd~ substrate carrying the same mutations, in the corresponding recombination assays with *attI1*~GCT~ and *attI1*~wt~ ([Table 4](#T4){ref-type="table"}).

Mutations of the third nt in the GTT triplet, or of the second and third nts at once indicate a higher sensitivity to G or C than A mutations
---------------------------------------------------------------------------------------------------------------------------------------------

Mutations in T^3^ are tolerable in *attC* × *attI1* recombination only when either the *attI1* or the *attC* site carries the mutation. When both of the sites are mutated we see a large decrease in recombination efficiency. Recombination with *attC*~aadA7GTA~/*attI1*~GTA~ is reduced 17-fold, while the same mutation in either *attC* or *attI1* by itself brings a recombination rate close to the wt one, or at most reduced by 2-fold. With the mutation T^3^→C^3^, we see a 150-fold decrease with *attC*~aadA7GTC~/*attI1*~GTC~, while either one of the mutations independently tested recombine at wt levels. This result was confirmed using an *attC*~VCRdGTC~ substrate with *attI1*~GTC~ and *attI1*~wt~, which generated similar results ([Table 4](#T4){ref-type="table"}).

The same pattern, but even more drastic, can be seen when both T^2^ and T^3^ are mutated at once. T^2^T^3^→A^2^A^3^ drops 700-fold when the mutation is present both in the *attC*~aadA7~ and the *attI1* site, from close to wt levels when only one site is carrying the mutation. The recombination frequency with the mutation T^2^T^3^→G^2^G^3^ drops by eight when the mutation is carried in the *attI1* site, by 160 when the mutation is present in the *attC*~aadA7~ site only, and by more than 10^4^ when recombination is performed with *attC*~aadA7GGG~/*attI1*~GGG~.

The recombination frequencies obtained with mutations in T^3^ or in T^2^ and T^3^ at once, follow the same general pattern, where IntI1 generally accepts one substrate with a mutation as recombination target. When both DNA targets are mutated, it has a dramatic impact on the recombination effect.

*In vitro* cleavage of *attC*~VCRd~ sites with mutations in the cleavage site
-----------------------------------------------------------------------------

We were interested to see if the results from the integration assay correlated with the proteins ability to recognize and cleave *attC* substrates carrying the corresponding mutations. Synthetic oligonucleotides of the *attC*~VCRd~ site with mutations in the cleavage site were labeled with P^32^ and incubated with purified HisIntI1~wt~ protein or a cleavage deficient mutant HisIntI1~Y312F~ In the cleavage assay we look at a cleavage product from a corresponding *attC* × *attC* complex. As one can see from [Figure 4](#F4){ref-type="fig"}, the substrates *attC*~VCRdGTC~ and *attC*~VCRdGGG~, which have a drastic impact on the recombination frequency are not detectably cleaved *in vitro* by the wt protein. With the substrate *attC*~VCRdGAA~, there is some *in vitro* cleavage, even though this mutation in the *attC~aadA7~* site shows a significant decrease in *attC* × *attI* recombination frequency ([Table 4](#T4){ref-type="table"}). Figure 4.Cleavage assay of different *attC*~VCRd~ site mutants by HisIntI1~wt~. In the different VCR~dXXX~ tested, the XXX nucleotides indicate the mutations made in the *attC*~VCRd~ cleavage site, the wild-type being GTT. The cleavage defective mutant HisIntI1~Y312F~ was used as a control. In the assay 30 pmol of HisIntI1~wt~ or HisIntI1~Y312F~ were used. Addition of either of the HisIntI1 proteins is indicated by a '+' sign in the corresponding row.

Mutations of the IntI1 residues interacting with the cleavage site and their effects on recombination
-----------------------------------------------------------------------------------------------------

The results from the mutations in the third nt could be explained by the specific interactions of the aa K171~IntI1~ from the attacking subunits with A^2′^ and T^3^ ([Figure 2](#F2){ref-type="fig"}B). We therefore assayed the mutants IntI1~K171R~ and IntI1~K171A~, in our *attC* × *attI1* recombination assay and found a 5-fold decrease in the recombination frequency with the mutant IntI1~K171A~, compared to IntI1~wt~, and no significant variation for IntI1~K171R~ ([Figure 3](#F3){ref-type="fig"}C).

In order to establish the importance of the non-specific interactions with the GTT triplet, mutations in the conserved cleavage-site interacting aa between IntI1 and VchIntIA, were made. H303~IntI1~ (H293~VchIA~) which is a member of the conserved HRHY motif of tyrosine recombinases ([@B18]), or Gly172~IntI1~ (Gly161~VchIntIA~) and Thr33~IntI1~ (Thr22~VchIntIA~), which are more than 3.5 Å away from the phosphate backbone ([@B8]) were not investigated. Instead we looked at the mutations Y37F~IntI1~ (Y26~VchIntIA~), H281I~IntI1~ (H271~VchIA~) and Y29F~IntI1~ (Y26~VchIntIA~), residues that are conserved between IntI1 and VchIntIA but not in other tyrosine recombinases. IntI1~Y29F~ had a recombination efficiency identical to the wt IntI1. However, we found a drastic decline of the recombination frequency, more than 10^5^-fold, for the IntI1~Y37F~ and IntI1~H281I~ mutants (data not shown). We were particularly interested in the IntI1~Y37F~ mutant. The superposition of the Int11 model ([@B15]), shows that the Y37F~IntI1~ (Y26~VchIntIA~), is in close proximity to the GTT strand of the substrate (\<5.0 Å). We decided to investigate the impact that this residue could have on the reaction, considering that the active site tyrosine (Y312~IntI1~) is positioned in a similar fashion with respect to the phosphate backbone but close to the cleaved C\|AA strand of the DNA, and that for a successful recombination reaction event to occur, there is a shared participation in the nature of the nts, and the surrounding protein environment. The region of cleavage is close to the unpaired segment of the substrate (the so-called central bubble) and therefore suffers from non-stacking disorder ([Figure 1](#F1){ref-type="fig"}). After cleavage and departure of the \|OH--C exchanged strand, one hypothesis would be that the Y37F~IntI1~ (Y26~VchIntIA~) hydroxyl could help stabilizing this part of the DNA (the GTT) through H-bond interaction with its backbone phosphate groups and thus preventing it from having alternative positions or trajectories due to flexibility ([@B8]). In support of this it was observed that the cleaved, assembled suicide substrate version of the VCRbs substrate does not crystallize with VchIntIA, whilst the LoxS--Cre complex does ([@B19]), in the latter this central region is fully base paired. This stability of the GTT is key since an incoming OH--C\* strand from the facing partner DNA would be arriving to read-out base matching and ligate to form the Holliday junction intermediate. As the histidine-tagged IntI1~wt~ had been shown to be recombinogenic ([@B15]), we created a his-tagged derivative of mutant IntI1~Y37F~ (HisIntI1~Y37F~, and purified it. This protein was found to have a poor DNA binding ([Figure 5](#F5){ref-type="fig"}). However, in EMSA experiments with mixed portions of HisIntI1~wt~ and HisIntI1~Y37F~, the mutant and the wt protein were found to bind cooperatively to DNA ([Figure 5](#F5){ref-type="fig"}). Figure 5.(**A**) EMSA experiment with HisIntI1~wt~ and HisIntI1~Y37F~ with the *attC*~VCRdwt~ substrate. The amount of protein used is indicated in the picture. One-eighth corresponds to 3.75 pmol, 1/4 to 7.5 pmol, 1/2 to 15 pmol and 1 corresponds to 30 pmol. In lane 10--12, HisIntI1~wt~ is kept constant at 15 pmol and an increasing amount of HisIntI1~Y37F~ is added, in lane 13--15 HisIntI1~Y37F~ is kept constant and HisIntI1~wt~ added in an increasing amount as indicated in the picture. (**B**) Graph showing the quantification of bound/(bound + free) product of HisIntI~wt~ (lanes 2--5) and HisIntI1~Y37F~ (lanes 6--9). (**C**) Graphs showing the quantification of the bound/(bound + free) product of constant HisIntI1~wt~ and variable HisIntI1~Y37F~ or constant HisIntI1~Y37F~ and variable HisIntI1~wt~. The curves are plotted together with the expected percent binding of the proteins, calculated by adding the binding of the corresponding concentration of the free proteins in lanes 2--9, if the binding of one protein was independent of the presence of the other.

It is possible that the mutation Y37F~IntI1~ leads to a looser interaction with, or a poorer recognition of the DNA which destabilizes the synaptic complex. The Y37 residue is positioned quite close (\<5 Å) to the GTT in the Int1 Model ([@B15]) with the possibility of interacting through H-bonds with the phosphate backbone, or ribosyl moiety of the G. Its replacement with a phenylalanine eliminates this possibility, therefore explaining the resulting drop in recombination frequency by a factor of 10^5^. Addition of the wt protein compensates for this loss of stabilizing interaction, if a shared complex is formed on the DNA. In this hypothesis, the wt partner on the GTT side will provide the specificity through H-bonds for initial binding, whilst the Y37 mutant once recruited in the *cis* side complex, goes on to form the known c-termini alpha-helix swap interaction in *trans*, as seen in the case of Cre and other recombinases, to generate the tetrameric synaptic complex. This increased stabilization prevents the wt from getting released, thus showing an overall increased binding.

DISCUSSION
==========

Our goal was to understand what governs the absolute conservation of the G^1^T^2^T^3^ triplets observed in the integron recombination sites, as all integrons characterized so far show the same conserved sites. We have shown that the G^1^T^2^T^3^ identity requirement between the *attI* and *attC* cleavage sites is not directed by an absolute requirement to obtain a successful recombination event (except for G^1^), or homology readout, since the cleavage sites are quite far away from each other in the synapse ([Figure 2](#F2){ref-type="fig"}A). The mutations in the first nt pair G^1^/C^3′^ support our hypothesis that there is only one nt responsible for the docking during the strand exchange event. In the integrative reaction of integrons, the linker regions, that are the regions between the two integrase binding sites of the *attC* and *attI* sites have no identity, in contrast to other tyrosine recombinase systems, such as for example Cre ([@B20]) ([Figure 2](#F2){ref-type="fig"}A).

The results obtained in the experiments where the second nt is mutated are extremely interesting, and in particular the observed increase in recombination frequency with the T^2^→A^2^ mutations ([Table 4](#T4){ref-type="table"}). It has been reported that the sequence GAT is a preferred secondary integration site over a GTT, in the absence of *attI1* ([@B21]). In addition, in their *attI1* study, Hansson and collaborators found that this T^2^→A^2^ substitution in one of the cleavage sites was the mutation that affected the recombination frequency to the least, (40% of the wt frequency) ([@B6]). The high tolerance for mutations in T^2^ in *attC*~aadA7~ × *attI1* recombination contrasts with the effect of the same mutations in one of the partner substrates in *attI1* × *attI1* recombination, implying different recombination determinants for the two reactions ([@B6]).

There seem to be several explanations for the results obtained with mutations in the third or in the second and third positions at once, of the cleavage site, T^3^/A^1′^ or T^2^T^3^/A^1′^A^2′^. The decrease in recombination frequency is 10--100-fold greater when Ts were mutated to G or C rather than to A. The mutations T^3^→A^3^ or T^2^T^3^→A^2^A^3^ should disturb neither the pairing of the DNA, nor its interactions with the catalytic subunits. The AT stacked structure differs somewhat from mixed AT--GC regions and could contribute to the reduction in recombination frequency ([@B22]). The AT rich tracks indeed have a propensity to have lower step sizes. They typically lack the amino exocyclic groups that exist in Guanine which through steric clashes, promote higher step sizes. Additionally, AT tracks exhibit a higher propeller twist, thus allowing these regions to have altered curvatures ([@B23]). Distorted geometry in one of the two partner sites appears to be tolerated but only on one of the two recombination substrates. The curvature imposed on the purine-rich side of the two strands and the increased propeller twist of the AT base pairs may significantly modify the ability of the integrase to recognize and bind to the DNA in this region.

The aa interacting with the cleavage site are conserved between VchIntIA and IntI1, with two exceptions, S30~IntI1~--A19~VchIntIA~ and R112~IntI1~--K101~VchIntIA~ ([Figure 2](#F2){ref-type="fig"}B). The protein--DNA interface is mainly due to non-specific interactions between the protein and the DNA backbone. There is only a single specific interaction: K171~IntI1~ (K160~VchIntIA~), which interacts specifically with nts T^3^ and A^2′^ flanking the scissile phosphate ([@B8]). The results from the mutations in the third nt could partly be explained by the specific interactions of the aa K171 from the attacking subunits. In the VchIntIA--VCRbs substrate crystal structure ([@B8]) this residue is seen to interact with the A14′ and T30 bases. The corresponding nts in the IntI1 substrate are A2′ and T3. The interaction is based on hydrogen bonds, with a 2.9 Å distance between the side-chain of K171 (Nz atom) with the A2′ N3 atom, and by a similar interaction (3.4 Å) between the same Nz atom and the O~2~ atom of the T3 base. Mutations in the third nt could abolish these bonds. We assayed the mutants IntI1~K171R~ and IntI1~K171A~, in our *attC* × *attI1* recombination assay and found a 5-fold decrease in the recombination frequency with the mutant IntI1~K171A~, compared to IntI1~wt~, and no significant variation for IntI1~K171R~ ([Figure 3](#F3){ref-type="fig"}C). This suggests that the NZ-N3 bound is conserved in IntI1-*attC* interaction and plays a role in the recombination. When both *attC*~aadA7~ and *attI1* are mutated there will be no specific interactions between IntI1 and the cleavage site. This also explains why the recombination frequency is lower when both T^2^ and T^3^ are mutated, since K171 interacts with both the second position of the cleaved strand, A^2′^ and with T^3^ on the opposite strand. Although the base at the A^2′^-T^3^ pair is not involved in the strand exchange, the reversal of the curvature due to the introduction of purines on the non-exchanging strand seems to play a critical role in reducing recombination frequency. This was supported by *in vitro* cleavage experiments with *attC*~VCRd~ probes carrying some of the mutations from the recombination experiments. Mutations G^1^→A^1^, G^1^→T^1^, T^2^→A^2^ and T^2^ T^3^→A^2^A^3^, were all cleaved, while no detectable cleavage product was generated with the mutations T^3^→C^3^ and T^2^ T^3^→G^2^ G^3^ ([Figure 4](#F4){ref-type="fig"}). IntI1 synaptic complex modeling suggests more specific interactions with G^1^ and T^3^ than for VchIntIA ([@B24]). This would further explain why mutations are more drastic with T^3^ in our experiments, than in T^2^. For G^1^, however, these interactions do not seem to be essential for recombination.

The investigations of the conserved aa Y37 and H281, which are involved in interactions with the cleavage-site, indicate the importance of the non-specific interactions with this site. The mutant HisIntI1~Y37F~ was found to bind DNA poorly. The equivalent residue in VchIntIA, Y26, is part of a hydrophobic core composed of (F12, Y18 and F77, VchIntIA coordinates). It seems likely that the protein--DNA interactions in the cleavage site help orient the DNA in the correct position for cleavage and recombination. It is possible that the decrease in recombination frequency with the IntI1~Y37F~ mutant is an effect of an unstable protein--DNA complex.

The conservation of an efficient recombination level when either the *attC*~aadA7wt~ site or *attI1* is mutated indicates that T^2^T^3^ in the G^1^T^2^T^3^ site was optimized for cleavage by the IntI1 protein rather than for homology requirements. Our results suggest that the G^1^T^2^T^3^ conservation is likely driven by the aptitude to exchange cassettes between the different integrons, more than by mechanistic grounds. We demonstrate that the recombination system of integrons class 1 has more relaxed requirements than previously thought. Regardless of the substitution, one mutation in the second or third nt of either *attC* or *attI* was highly tolerated by the integrase protein, and a recombination frequency compared to that of the wt was obtained. In addition these studies, by showing that the first nt of the conserved triplet can be substituted without harm, open the way for the utilization of the integron recombination machinery in synthetic biology. This shows that recombination of sequence 'à la carte' is certainly an objective that can be reached starting from the integron system. Indeed, we had previously established which of the secondary structure features are directing the recombined strand recognition ([@B9]). Now we show that to accomplish a successful recombination, in contrast to other known tyrosine recombination systems, the conserved triplet of the Recombinase binding element sequence is highly tolerant for substitutions and that the only absolute requirement is identity of the first nt in the two partner sites.
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